Ultrasound-Mediated Vascular Gene Transfection by Cavitation of Endothelial-Targeted Cationic Microbubbles  by Xie, Aris et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 5 , N O . 1 2 , 2 0 1 2
© 2 0 1 2 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 2 . 0 5 . 0 1 7Ultrasound-Mediated Vascular Gene Transfection by
Cavitation of Endothelial-Targeted Cationic Microbubbles
Aris Xie, BS,* Todd Belcik, RDCS,* Yue Qi, MD,* Terry K. Morgan, MD, PHD,†
Shivam A. Champaneri, MD,‡ Sarah Taylor, PHD,‡ Brian P. Davidson, MD,*
Yan Zhao, MS,* Alexander L. Klibanov, PHD,‡ Michael A. Kuliszewski, BS,§
Howard Leong-Poi, MD,§ Azzdine Ammi, PHD,* Jonathan R. Lindner, MD*
Portland, Oregon; Charlottesville, Virginia; and Toronto, Ontario, Canada
O B J E C T I V E S Ultrasound-mediated gene delivery can be ampliﬁed by acoustic disruption of
microbubble carriers that undergo cavitation. We hypothesized that endothelial targeting of micro-
bubbles bearing cDNA is feasible and, through optimizing proximity to the vessel wall, increases the
efﬁcacy of gene transfection.
B A C KG ROUND Contrast ultrasound-mediated gene delivery is a promising approach for site-
speciﬁc gene therapy, although there are concerns with the reproducibility of this technique and the
safety when using high-power ultrasound.
METHOD S Cationic lipid-shelled decaﬂuorobutane microbubbles bearing a targeting moiety were
prepared and compared with nontargeted microbubbles. Microbubble targeting efﬁciency to endothe-
lial adhesion molecules (P-selectin or intercellular adhesion molecule [ICAM]-1) was tested using in vitro
ﬂow chamber studies, intravital microscopy of tumor necrosis factor-alpha (TNF-)–stimulated murine
cremaster muscle, and targeted contrast ultrasound imaging of P-selectin in a model of murine limb
ischemia. Ultrasound-mediated transfection of luciferase reporter plasmid charge coupled to micro-
bubbles in the post-ischemic hindlimb muscle was assessed by in vivo optical imaging.
R E S U L T S Charge coupling of cDNA to the microbubble surface was not inﬂuenced by the presence of
targeting ligand, and did not alter the cavitation properties of cationic microbubbles. In ﬂow chamber studies,
surface conjugation of cDNA did not affect attachment of targeted microbubbles at microvascular shear
stresses (0.6 and 1.5 dyne/cm2). Attachment in vivo was also not affected by cDNA according to intravital
microscopy observations of venular adhesion of ICAM-1–targetedmicrobubbles and by ultrasoundmolecular
imaging of P-selectin–targeted microbubbles in the post-ischemic hindlimb in mice. Transfection at the site
of high acoustic pressures (1.0 and 1.8 MPa) was similar for control and P-selectin–targeted microbubbles but
was associated with vascular rupture and hemorrhage. At 0.6 MPa, there were no adverse bioeffects, and
transfection was 5-fold greater with P-selectin–targeted microbubbles.
CONC L U S I O N S We conclude that ultrasound-mediated transfection at safe acoustic pressures
can be markedly augmented by endothelial juxtaposition. (J Am Coll Cardiol Img 2012;5:1253–62)
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1254ntegration of gene therapy into routine clinical
practice patients is predicated on the ability to
safely and efficiently deliver genetic material to
target tissues in a manner that favorably alters cell
phenotype. Ultrasound energy can amplify transfer
of genetic material into cells of target tissues in vivo,
the extent of which is further increased by the
coadministration of ultrasound contrast agents
composed of protein- or lipid-stabilized gas micro-
bubbles (1–6). Contrast ultrasound-mediated gene
delivery (CUMGD) and transfection appears to be
most effective when genetic material is coupled to
the contrast agent surface (7,8).
See page 1263
The observation that CUMGD increases extrav-
asation and cellular uptake of cDNA strongly sug-
gests that local bioeffects produced by microbubble
cavitation is responsible for increased transfection
efficiency (4,8,9). In an ultrasound field,
microbubble contrast agents undergo ei-
ther stable cavitation (volumetric oscilla-
tion linearly related to acoustic pressure)
or inertial cavitation (high-amplitude
nonlinear oscillation and physical disrup-
tion). Cavitation produces oscillatory
shear, high-pressure microstreaming, and
physical stretching of endothelial cells
(10,11). These local effects can produce
physical and functional changes in adjacent
cells, such as microporation (2,8,9,12), en-
hanced permeability through intercellular
junctions (13), and triggering of active cel-
lular uptake of macromolecules (14).
Irrespective of the mechanism(s) responsible for
CUMGD, the proximity of the contrast agent to
the cell surface is likely to be a critical determinant.
In vivo, this translates to proximity to the vascular
wall since in most tissues microbubbles possess a
rheology similar to erythrocytes and remain entirely
within the vascular compartment (15). Accordingly,
endothelial targeting of ultrasound contrast agents
via surface conjugation of ligands could amplify
CUMGD by promoting vascular juxtaposition (16).
On the other hand, direct apposition of ultrasound
contrast agents to the endothelial surface by target-
ing may not necessarily convey benefit in tissues
such as the heart, brain, or skeletal muscle where
the majority of microbubbles during CUMGD are
resident within capillaries and small noncapillary
microvessels, where bubbles are already in proximity
nd-
n
y
sticto the vessel boundaries. The aim of this study was eto investigate whether it is feasible to target DNA-
laden microbubbles to the endothelial surface and
to determine the relative benefit of using a vascular-
targeted approach in terms of both efficacy and
safety of transfection for CUMGD.
M E T H O D S
Microbubble preparation. Lipid-shelled decafluoro-
butane microbubbles with a neutral charge were pre-
pared by sonication of a gas-saturated aqueous sus-
pension of distearoylphosphatidylcholine (2 mg/ml)
and polyoxyethylene-40-stearate (1 mg/ml). Cationic
bubbles were prepared by adding distearoyl-
trimethylammoniumpropane (0.4 mg/ml) to the aque-
ous suspension. For biotinylated cationic or neutral
microbubbles, distearoylphosphatidyl-ethanolamine–
polyethyleneglycol-2000 (DSPE-PEG2000) biotin (0.1
mg/ml) was added to the aqueous suspension. Fluores-
cent labeling for intravital microscopy was performed by
adding dioctadecyl-tetramethylindocarbocyanine
perchlorate (DiI) or dioctadecyloxacarbocyanine
perchlorate (DiO). Targeted microbubbles were
prepared by conjugating biotinylated monoclonal
antibodies (mAb) to the surface of cationic biotin-
ylated microbubbles via a streptavidin link as
previously described (16). Antibodies included
rat anti-mouse P-selectin (RB40.34), intercellular
adhesion molecule-1 (ICAM-1) (3E2, BD Phar-
mingen, San Jose, California), and isotype con-
trol mAb (R3-34, BD Pharmingen). Plasmid
cDNA was charge coupled to microbubbles by
incubation of 50 g per 108 microbubbles for 15
min, which produces near saturation (8), and for
targeted microbubbles was performed after mAb
conjugation. The mean diameter and concentra-
tion of microbubbles was determined by electro-
zone analysis (Multisizer III, Beckman Coulter,
Fullerton, California). Electric surface potential
(zeta potential) for cationic and neutral micro-
bubbles was determined by measurement of their
electrophoretic mobility (ZetaPALS, Brookhaven In-
struments, Holtsville, New York) in 1 mmol/l KCl at
pH 7.4.
Microbubble–plasmid coupling. Quantitation of
icrobubble-associated cDNA was performed by
uorescent labeling of plasmid (pCMV-GL3, Pro-
ega, Madison, Wisconsin) with SYBR-Gold (In-
itrogen, Carlsbad, California). Microbubbles were
eparated from the aqueous suspension and washed
y flotation centrifugation. After hyperbaric de-
truction of microbubbles, the cDNA content wasA B B R E V I A T I O N S
A N D A C R O N YM S
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1255XPS, Molecular Devices, Sunnyvale, California)
compared with a standard.
Characterization of microbubble cavitation. Saline
alone or suspensions of cationic microbubbles (1 
107 ml1) with and without cDNA were infused
through acoustically transparent tubing (2-mm in-
ternal diameter, 0.9 ml/min) and were exposed to
ultrasound (1 MHz, 30-cycle pulses at a pulse
repetition frequency of 50 Hz) at either 0.5- or
1.0-MPa peak negative acoustic pressure (PNAP)
using a single-element transducer (Olympus NDT,
Olympus, Tokyo, Japan) and a random waveform
generator (RAM-5000, Ritec, Warwick, Rhode
Island). A second broadband (10 KHz to 20 MHz)
transducer was placed at a 60° angle as a passive
cavitation detector and was interfaced with a re-
ceiver (RAM-5000, Ritec) and an oscilloscope
(44MXi-A, Teledyne LeCroy, Chestnut Ridge,
New York). Acoustic response was quantified by
both initial signal amplitude and rate of signal decay
indicating inertial cavitation.
Flow chamber studies. Streptavidin (0.25 mg/ml) was
dsorbed on the surface of the disposable component
f an inverted flow chamber (GlycoTech, Gaithers-
urg, Maryland) and blocked with casein. The flow
hamber was mounted on a microscope, and micro-
ubble adhesion to either streptavidin-coated or con-
rol (casein only) plates was assessed using 8 different
icrobubble preparations according to the following
ariables: biotinylated versus nonbiotinylated, cat-
onic versus neutral, with versus without plasmid
DNA (pCMV-GL3, Promega). Microbubble sus-
ensions (1  106 ml1) were infused for 5 min at
shear rate of 0.6 or 1.5 dyne/cm2, after which
dhesion density was averaged from 10 optical
elds. Each of the 32 experimental conditions was
erformed in triplicate.
Intravital microscopy. To test binding efficiency in
ivo, intravital microscopy of the cremaster muscle
as performed in 5 C57BL/6 mice 8 to 12 weeks of
ge 1 h after intrascrotal injection of TNF- (0.5
g in 100 l). The cremaster muscle was prepared
or intravital microscopy as previously described
16,17). Microbubble adhesion was tested for 4
eparate cationic microbubble preparations accord-
ng to the following 2 variables: ICAM-1–targeted
r nontargeted control microbubbles, presence or
bsence of plasmid cDNA on the surface. Micro-
ubbles (1  107) were injected intravenously, and
adhesion was assessed 5 min later by fluorescent
microscopy in 20 optical fields (total area: 1 mm2).
Differential labeling of microbubbles with DiI and mDiO allowed simultaneous injection of 2 agents at a
time.
Contrast ultrasound molecular imaging. Contrast-
nhanced ultrasound (CEU) molecular imaging of
ndothelial activation was performed to further
valuate the effect of gene loading on microbubble
dhesion. Unilateral hindlimb ischemia (20-min
liac ligation) and reperfusion was performed in 10
57BL/6 mice anesthetized with inhaled isoflu-
ane. CEU perfusion imaging was performed to
valuate microvascular blood flow in the proximal
indlimb adductor muscles during arterial ligation
nd approximately 45 min after reflow. For perfu-
ion imaging, a continuous infusion of micro-
ubbles (1  106 min1) was used. Flow was
quantified from the product of microvascular blood
volume and flux rate derived from post-destruction
time-intensity data acquired using a linear-array
transducer and a contrast-specific multipulse tech-
nique (Contrast-Pulse Sequencing, Sequoia, Sie-
mens Medical Systems, Mountain View, Califor-
nia) operating at a transmission frequency of 7.0
MHz and a mechanical index (MI) of 0.16 (18).
Absolute microvascular blood flow was calculated
by normalizing muscle microvascular blood vol-
ume to the blood pool and dividing by tissue
density (1.06 g/cm3). Thirty minutes after reflow,
or after similar anesthesia time in nonischemic
controls, molecular imaging of retained micro-
bubbles was performed. Signal from retained
microbubbles was calculated from a high-MI
(1.0) image obtained 8 min after intravenous
injection, from which signal from freely circulat-
ing microbubbles was eliminated by digital sub-
traction of frames subsequently obtained at a
pulsing interval of 10 s (16). P-selectin–targeted
microbubbles with or without plasmid were
tested in random order.
Targeted gene transfection. Targeted CUMGD was
performed in the model of post-ischemic hindlimb
skeletal muscle in 42 C57BL/6 mice 10 to 12 weeks
of age. For these experiments, both hindlimbs
underwent ischemia-reperfusion injury. Thirty
minutes after reflow, either nontargeted or P-
selectin–targeted cationic microbubbles (2  108)
ombined with a firefly luciferase (luc2) reporter
lasmid with an SV40 promoter region (pGL4.13,
romega) was infused intravenously over 1 min.
he proximal adductor muscles of only the left
indlimb were exposed to ultrasound during the
njection and for an additional 9 min. Transducers
ere placed at a fixed distance (2 cm) from the
id-portion of the muscle using a transverse imag-
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1256ing plane. Ultrasound exposure was performed us-
ing harmonic power Doppler imaging (Sonos 7500,
Philips Ultrasound, Andover, Massachusetts) at 1.6
MHz, a pulsing interval of 5 s, a pulse repetition
frequency of 2.5 kHz, and a MI of 0.6, 1.3, or 2.4.
Acoustic pressures at the level of the muscle were
measured by a 0.075-mm needle hydrophone (Pre-
cision Acoustics, Dorchester, United Kingdom).
Animals were recovered and in vivo assessment of
transfection was determined by optical imaging of
luciferase activity 3 days later. D-luciferin (0.15
mg/g) was administered by intraperitoneal injec-
tion. Animals were anesthetized with inhaled iso-
flurane and placed in an optical imaging system
(IVIS Spectrum, Caliper Life Sciences, Hopkinton,
Massachusetts). Bioluminescent activity was mea-
sured 10 min after luciferin injection with an open
emission filter and medium binning. Light activity
from regions of interest placed over each proximal
hindlimb was quantified by total photon flux
(photons/s).
Luciferase mRNA. Luciferase mRNA in muscle tis-
sue was measured by real-time polymerase chain
reaction (PCR) in an additional 36 mice receiving
either P-selectin–targeted (n  18) or nontargeted
n  18) microbubbles (see Online Methods).
Vascular permeability and hemorrhage. In order to
assess vascular permeability, intravenous injection
of Texas Red–labeled dextran (70,000 molecular
weight) was performed immediately before con-
trast ultrasound in an additional 14 mice. After
the 10-min ultrasound exposure, fluorescent in-
tensity in the ultrasound-exposed and control
hindlimbs were measured with the in vivo optical
imaging system using a 605-nm excitation wave-
length and emission filters of 660 to 780 nm.
Spectral unmixing was performed to correct for
autofluorescence. Upon completion of imaging,
the skin was removed, and the adductor muscles
were examined for petechiae, which were graded
as 0 (none), 1 (sparse), 2 (moderate), and 3
(severe).
Histology. Three days after CUMGD, muscle tis-
ue from ultrasound-exposed and control hindlimbs
as fixed and embedded in paraffin. Immunohisto-
hemistry was performed using goat anti-luciferase
olyclonal primary antibody (Promega, 1:200 dilu-
ion) primary mAb and secondary anti-goat IgG
onjugated to horseradish peroxidase reporter
ImmPRESS, Vector Laboratories, Burlingame,
alifornia) with 3,3= diaminobenzidine chromagen
Vector Laboratories) detection. To assess the late
ioeffects of microbubble destruction, Masson’srichrome staining was performed from the control
nd ultrasound-exposed hindlimb tissue from mice
days after exposure (n  2 for each acoustic
power).
Statistical analysis. Data were analyzed using RS/1
(Domain Manufacturing Corp., Burlington, Mas-
sachusetts). All data are displayed as mean  SD
unless otherwise specified. For normally distributed
data, 1-way analysis of variance was performed for
normally distributed variables with post hoc testing
of individual comparisons with paired or unpaired
t test as appropriate. Bonferroni correction was
applied for multiple comparisons. Gene transfec-
tion data were not normally distributed and were
compared with a Mann-Whitney test. Values of
p  0.05 were considered to be statistically
significant.
R E S U L T S
Microbubble carrier characteristics. There were no
ignificant differences in either mean diameter
range: 2.5 to 3.1 m) or size distribution between
he 4 different microbubble agents tested. The zeta
otential for nonbiotinylated microbubbles was sig-
ificantly greater for cationic compared with neutral
icrobubbles (64  5 mV vs. 1  2 mV, p 
.001). When microbubbles were biotinylated
hrough addition of DSPE-PEG-biotin in the
hell, there was a significant (p  0.05) negative
hift in the zeta potential for both cationic (56 
mV) and “neutral” (13  2 mV) microbubbles,
hich was presumably attributable to the biotin
omponent (isoelectric point pH  3.5). Charge
coupling of plasmid cDNA to the microbubble
surface detected by SYBR-gold labeling (Fig. 1A)
occurred only for cationic microbubbles and was
not altered by biotinylation despite the small
change in zeta potential produced by biotinyla-
tion (Fig. 1B). The acoustic response from cat-
ionic microbubbles at PNAP of 0.5 and 1.0 MPa,
measured by both the initial signal amplitude
from cavitation on the first pulse and by the rate
of cavitation-related signal decay, was not sub-
stantially affected by surface coupling of cDNA
(Figs. 1C and 1D).
Inﬂuence of cDNA on microbubble targeting. Flow
chamber evaluation of microbubble attachment to
adsorbed streptavidin was used to evaluate
whether charge coupling of cDNA to the surface
of targeted microbubbles impaired their adher-
ence to surfaces in flow conditions (Fig. 2A). At
shear stresses of 0.6 and 1.5 dyne/cm2, there was
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1257minimal nonspecific attachment of nonbiotiny-
lated microbubbles to streptavidin, irrespective of
microbubble surface charge or incubation with
plasmid cDNA. Attachment density was high for
neutral biotinylated microbubbles and was not
altered by incubation with plasmid cDNA, which
was anticipated because of the minimal amount
of cDNA that is charge coupled with neutral
agent. In the absence of plasmid cDNA, attach-
ment of biotinylated microbubbles was signifi-
cantly less for cationic versus neutral micro-
bubbles. Interestingly, the deficit in attachment
for cationic biotinylated microbubbles was cor-
rected by plasmid cDNA coupling to the micro-
bubble surface. In both shear conditions, nonspe-
cific attachment to plates without streptavidin
was minimal (5 per optical field) for all 8
microbubble preparations.
Intravital microscopy of TNF-–treated cre-
master muscle in mice was used to evaluate
Figure 1. Properties of Lipid Microbubble Carriers
(A) Fluorescent microscopy (excitation ﬁlter 530 to 560 nm) of SYBR
bubbles (scale bar  5 m). (B) Mean  SD amount of cDNA charg
Biot  presence of DSPE-PEG-biotin. *p  0.01 versus both neutral
by microbubble cavitation during ultrasound exposure at 1 MPa us
pressure waveform for the second pulse is expanded. (D) Mean 
passive cavitation detector for cationic microbubbles with and with
MPa peak negative acoustic pressure. The eventual stabilization aft
obtained with saline alone (Online Fig. 1).whether surface coupling of cDNA interfereswith the in vivo vascular adhesion of targeted
microbubbles in an inflammatory disease–related
model. Fluorescently labeled microbubbles re-
mained entirely intravascular after their intrave-
nous injection and were cleared from the circu-
lation after 5 min. There was minimal attachment
of nontargeted cationic microbubbles (Fig. 2B).
Targeting microbubbles to ICAM-1 by surface
conjugation of anti-mouse ICAM-1 mAb in-
creased microvascular retention, the extent of
which was not altered by the presence of plasmid
cDNA. Almost all attachment was secondary to
venular endothelial attachment.
Noninvasive CEU molecular imaging of endo-
thelial P-selectin in a model of murine hindlimb
ischemia-reperfusion injury was performed to fur-
ther evaluate whether gene loading influences mi-
crobubble adhesion. During iliac artery ligation,
flow was reduced to 0.04  0.01 ml/min/g and
increased to 0.47  0.20 ml/min/g at the comple-
ld–labeled plasmid cDNA charge coupled to cationic micro-
oupled to the surface of different microbubble preparations.
parations. (C) Example of an acoustic amplitude response caused
30-cycle ultrasound pulses every 20 ms (50 Hz). A portion of the
mplitude of microbubble response (peak-to-peak) measured by a
cDNA during sequential 1-MHz ultrasound pulses at 0.5- and 1.0-
proximately pulse 10 was not signiﬁcantly different from that-go
e c
pre
ing
SD a
out
er aption of molecular imaging 45 min after reflow.
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1258Retention of targeted microbubbles on CEU was
evaluated after intravenous injection of microbubble
preparations performed between 30 and 45 min
after release of the arterial ligature. Retention was
greater for P-selectin–targeted versus nontargeted
microbubbles and was not substantially affected by
surface coupling of plasmid cDNA (Fig. 3).
Reporter gene transfection. Targeted CUMGD of
refly luciferase reporter plasmid (pGL4.13) was
ssessed in post-ischemic hindlimb skeletal muscle.
or these experiments, both hindlimbs underwent
schemia-reperfusion injury, and only the left prox-
mal hindlimb was exposed to ultrasound. The
NAP for the 3 CUMGD ultrasound settings (MI
.6, 1.3, and 2.4) were 0.6, 1.0, and 1.8 MPa,
espectively. Gene transfection quantified 3 days
ater by whole-body in vivo optical imaging of
Figure 2. Microbubble Adhesion Efﬁciency
(A) In vitro microbubble attachment density per optical ﬁeld (OF) to
for shear stresses of 0.6 and 1.5 dyne/cm2. *p  0.05 versus both t
biotinylated preparation with cDNA. (B) Illustrative image and quan
targeted microbubbles observed by intravital microscopy in TNF-–tre
labeled ICAM-1–targeted microbubbles in a venule running vertically a
targeted agent.uciferase activity was detected only at the site of pltrasound exposure (Fig. 4). Luciferase activity at
he 2 highest acoustic pressure conditions (1.0 and
.8 MPa) was similar for P-selectin–targeted and
ontargeted microbubbles (Fig. 4A). Luciferase
ctivity was lower at an acoustic pressure of 0.6
Pa. At this lower pressure, transfection was sig-
ificantly greater (approximately 5-fold) and more
eproducible for the P-selectin–targeted micro-
ubbles. Similar results were found for luciferase
ene expression by real-time PCR, which was no
ifferent for the 2 agents at 1.8 MPa but was higher
or targeted compared with nontargeted micro-
ubbles at 0.6 MPa (31,152 26,022% vs. 7,090
,155% relative to GAPDH, p  0.05). Immuno-
istochemistry showed that the majority of lucifer-
se transfection occurred in microvascular endothe-
ial cells, smooth muscle cells, and surrounding
eptavidin-coated plates in a ﬂow chamber. Data are displayed
orresponding neutral biotinylated preparation and the cationic
ive data for in vivo attachment of cationic nontargeted or ICAM-1–
cremasteric vessels. The image illustrates retention of DiI-
s the image (scale bar: 20 m); *p  0.05 versus corresponding non-str
he c
titat
ated
croserivascular cells irrespective of acoustic conditions
a
g
w
b
i
i
u
u
i
i
w
a
m
fi
t
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 1 2 , 2 0 1 2
D E C E M B E R 2 0 1 2 : 1 2 5 3 – 6 2
Xie et al.
Targeted Ultrasound Gene Delivery
1259and microbubble preparation (Fig. 4C). Greater
transfection for the targeted agent tended to be due
to greater noncapillary microvascular endothelial
transfection.
Bioeffects of cavitation. Although the 2 highest
coustic pressures (1.0 and 1.8 MPa) produced the
reatest luciferase transfection on CUMGD, they
ere also associated with the presence of adverse
ioeffects evidenced by petechial bleeding on gross
nspection (Fig. 5A). Petechiae were not observed
n any animal exposed to low-pressure (0.6 MPa)
ltrasound. Yet vascular permeabilization in the
ltrasound-exposed limb, detected by optical imag-
ng of Texas Red–dextran accumulation in tissue
mmediately after ultrasound exposure (Fig. 5B),
as similar for 0.6 and 1.0 MPa and actually lower
t 1.8 MPa. Histology 5 days after ultrasound and
icrobubble exposure did not find any evidence for
brosis in the muscle or anterior subcutaneous
issues even after exposure at 1.8 MPa (Fig. 5C).
D I S C U S S I O N
The aim of this study was to test the hypothesis that
juxtaposition of cationic microbubble carriers to the
vessel wall would increase CUMGD. Our results
indicate that when using very high acoustic pres-
sures that also produce adverse bioeffects,
endothelial-targeting of microbubbles during
CUMGD does not further augment gene transfec-
tion. At lower acoustic pressures that did not
produce adverse bioeffects, transfection of vascular
cells was substantially increased by endothelial tar-
Figure 3. Molecular Imaging of Microbubble Attachment Efﬁcie
(A) Quantitative acoustic signal intensity (AU) corrected for freely ci
sponding nontargeted agent. (B) Examples of contrast-enhanced ul
cle 8 min after intravenous injection for control (Co) or P-selectin–t
and subtracted for freely circulating agent.geting, indicating that this is a feasible approach forbalancing transfection efficiency and safety for gene
therapy in diseases characterized by specific endo-
thelial epitopes.
Part of the novelty of this study was to create
cationic microbubbles with a targeting moiety.
With regard to microbubble design, the targeting
ligand was conjugated at the end of a long PEG
spacer that was intended to allow interaction with
endothelial cell adhesion molecules despite charge-
mediated layering of cDNA on the microbubble
surface. Images obtained by fluorescent labeling
indicated relatively uniform rather than eccentric
(flocculent) coverage of plasmid on the microbubble
surface, and that microbubble aggregation that can
occur with plasmid-shell coupling was relatively
low. Our flow chamber studies indicated that
cDNA coupling to the surface of microbubbles did
not interfere with targeting, but actually increased
attachment for cationic microbubbles. This phe-
nomenon was not because of nonspecific interac-
tions between cDNA and streptavidin plates that
were absent in control experiments. Instead, it is
likely that the genetic material acted to prevent
interactions between the cationic lipid shell and
the biotin moiety, potentially “straightening” the
PEG brush. In vivo studies using intravital mi-
croscopy and CEU molecular imaging showed no
effect of surface coupling of cDNA on either
ICAM-1 or P-selectin targeting. ICAM-1 was
selected in this model rather than P-selectin
because the latter is also affected to varying
degrees simply by surgical exteriorization of the
ating contrast for nontargeted control. *p  0.05 versus corre-
und images obtained of the post-ischemic hindlimb skeletal mus-
ted (Targ) microbubbles. Images are color coded (scale at left)ncy
rcul
traso
argemuscle (17). These experiments confirmed that
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1260the presence of cDNA on cationic microbubble
carriers does not interfere with ligand-mediated
endothelial attachment under microvascular shear
conditions.
The ultrasound conditions during CUMGD are
important when assessing the relative benefit of
targeting. In our experiments, we chose an ultra-
sound pulsing interval of 5 s. This is approximately
half the time required for total microvascular refill
for microbubbles in skeletal muscle after a destruc-
tive pulse (18,19). This scheme allowed us to
destroy all microbubbles transiting through the
microcirculation within the ultrasound beam and to
test the effects of endothelial juxtaposition without
any differences in the cumulative number of tar-
geted versus nontargeted microbubbles undergoing
cavitation.
There is clear evidence that vascular events
Figure 4. Targeted Transfection of Luciferase Reporter Plasmid
(A) In vivo optical imaging data of luciferase reporter gene trans
of ultrasound exposure 10 min after intraperitoneal injection of
was signiﬁcantly lower at 0.6 MPa compared with 1.0 and 1.8 M
coded) 3 days after bilateral hindlimb ischemia and intravenous
coupled cationic microbubbles during ultrasound at 0.6 MPa. Ve
(C) Immunohistochemistry for luciferase with peroxidase illustrat
perivascular cells. Scale bar  50 m.other than overt vascular rupture are responsiblefor gene transfection with CUMGD (11,14,20).
Our aim was to safely amplify gene transfection
by targeting cationic microbubble carriers to the
vascular endothelium. Our in vivo transfection
studies demonstrated successful CUMGD at the
site of ultrasound in all animals. CUMGD with
high pressure ultrasound (1.0 to 1.8 MPa) re-
sulted in a high amount of transfection. However,
there were also cavitation-related microvascular
ruptures that have been previously described with
high-power ultrasound and large doses of micro-
bubble contrast agents (21). There were also no
differences in transfection for targeted versus
nontargeted microbubbles at high power. It is
likely that violent cavitation at high acoustic
pressures produced large-pressure microstreams
and vascular effects conducive to transfection
irrespective of microbubble position relative the
ion 3 days after CUMGD, quantiﬁed as photon ﬂux at the site
erin. PNAP  peak negative acoustic pressure. Transfection
or both agents. (B) Examples illustrating luminescence (color-
ction of either nontargeted or P-selectin–targeted cDNA-
l surface depiliation was performed to reduce light attenuation.
transfection (arrows) of venular and capillary endothelium andfect
lucif
Pa f
inje
ntra
ingvascular wall. At 0.6 MPa, there was 5 times
g
n
or
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1261greater transfection for targeted versus nontar-
geted microbubbles, and there were no petechial
hemorrhages. Yet, at this pressure vascular per-
meabilization assessed by Texas Red–labeled dex-
tran accumulation did not appear to be any less
than at the higher pressures, indicating that
cavitation may increase permeability in the ab-
sence of severe vascular damage. We believe that
the slightly lower signal for Texas red–labeled
Figure 5. Bioeffects From CUMGD Measured Immediately After
(A) Examples showing no petechiae or moderate petechiae at the s
of 0.6 and 1.8 MPa, respectively, and percentage of animals with ea
dextran from the ultrasound-exposed and control leg immediately
of in vivo optical imaging (color-coded and superimposed on brigh
to eliminate bladder signal. (C) Masson’s trichrome imaging illustrat
lar pattern in tissue exposed to microbubbles and ultrasound at 0.6dextran accumulation at 1.8 MPa was probably Obecause of early interruption of flow caused by
hemorrhagic bioeffects at this pressure. Interest-
ingly, Masson’s trichrome staining showed no
histological evidence for significant long-term
effects from high-power ultrasound despite the
presence of petechiae.
Study limitations. First, we assessed the location of
ene transfection 3 days after transfection but did
ot directly evaluate the location of gene delivery.
asound Exposure
of ultrasound exposure at peak negative acoustic pressures (PNAP)
etechia score. (B) Quantitative ﬂuorescence for Texas Red–
contrast ultrasound-mediated gene delivery (CUMGD). Examples
ht images) are shown at the right with a mid-line shield placed
absence of signiﬁcant ﬁbrosis (blue) other than normal perivascu-
1.8 MPa.Ultr
ite
ch p
after
t lig
ingur previous studies using intravital microscopy
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1262have demonstrated mainly endothelial and
perivascular deposition (8). Also, we did not
evaluate the effects of different ultrasound pulsing
intervals or frequencies. As mentioned previ-
ously, we chose our pulsing interval in order to
provide equipoise for comparing our 2 agents.
We also believe that the benefit of cationic
microbubble targeting will need to be demon-8. Christiansen JP, French BA, Klibanov
AL, Kaul S, Lindner JR. Targeted
1
1
1
1
1
1
2002;15:396–403.therapeutic target for pro-angiogenic gene
therapy.
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